Procaps Group S.A. (PROC)
USD 1.01
(0.0%)
USD 1.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | 52.32 Million USD | 661.86% |
| 2021 | -5.28 Million USD | -108.76% |
| 2020 | 60.35 Million USD | 66.43% |
| 2019 | 36.26 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | 33.39 Million USD | 407.57% |
| 2023 Q3 | 11.37 Million USD | -65.96% |
| 2023 Q1 | 6.58 Million USD | -83.79% |
| 2022 Q2 | 9.49 Million USD | 326.68% |
| 2022 Q1 | 2.22 Million USD | 106.78% |
| 2022 Q4 | 40.59 Million USD | 134.01% |
| 2022 FY | 29.71 Million USD | 661.86% |
| 2022 Q3 | 17.34 Million USD | 82.63% |
| 2021 Q4 | -32.85 Million USD | -278.54% |
| 2021 Q3 | 18.4 Million USD | 13.83% |
| 2021 Q1 | -372 Thousand USD | -101.0% |
| 2021 FY | -5.28 Million USD | -108.76% |
| 2021 Q2 | 16.16 Million USD | 4445.43% |
| 2020 Q1 | -3.02 Million USD | -132.3% |
| 2020 Q4 | 37.07 Million USD | 161.39% |
| 2020 Q3 | 14.18 Million USD | -4.27% |
| 2020 Q2 | 14.81 Million USD | 590.14% |
| 2020 FY | 60.35 Million USD | 66.43% |
| 2019 FY | 36.26 Million USD | 0.0% |
| 2019 Q2 | 9.35 Million USD | 0.0% |
| 2019 Q1 | 9.35 Million USD | 0.0% |
| 2019 Q4 | 9.35 Million USD | 0.0% |
| 2019 Q3 | 9.35 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 133.635% |
| Theratechnologies Inc. | -10.62 Million USD | 592.368% |
| Safety Shot Inc | -12.18 Million USD | 529.443% |
| Cosmos Health Inc. | -21.83 Million USD | 339.675% |
| Cronos Group Inc. | -81.37 Million USD | 164.299% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 74.969% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 233.64% |
| Organogenesis Holdings Inc. | 12.52 Million USD | -317.756% |
| Universe Pharmaceuticals INC | -3.52 Million USD | 1583.622% |
| ProPhase Labs, Inc. | -21.61 Million USD | 342.095% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | 1213.04% |
| Dynavax Technologies Corporation | -37.02 Million USD | 241.309% |
| Radius Health, Inc. | -3.92 Million USD | 1433.096% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | 2180.298% |
| Alvotech | -354.86 Million USD | 114.745% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 1193.432% |
| Alpha Teknova, Inc. | -35.56 Million USD | 247.13% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 132.83% |
| SCYNEXIS, Inc. | 72.66 Million USD | 27.997% |
| Harrow Health, Inc. | 580 Thousand USD | -8921.379% |
| Biofrontera Inc. | -22.67 Million USD | 330.736% |
| DURECT Corporation | -36.88 Million USD | 241.861% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | 1093.054% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | -11.396% |
| OptiNose, Inc. | -22.74 Million USD | 330.016% |
| RedHill Biopharma Ltd. | 12.63 Million USD | -314.218% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 446.471% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | 942.465% |
| SIGA Technologies, Inc. | 83.62 Million USD | 37.427% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | -460.754% |
| Shineco, Inc. | -17.06 Million USD | 406.6% |
| Phibro Animal Health Corporation | 53.31 Million USD | 1.859% |
| TherapeuticsMD, Inc. | -8.52 Million USD | 713.915% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | 1204.645% |
| Viatris Inc. | 766.2 Million USD | 93.171% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 1193.432% |
| Rockwell Medical, Inc. | -6.67 Million USD | 884.468% |
| Incannex Healthcare Limited | -30.04 Million USD | 274.175% |
| Aytu BioPharma, Inc. | -5.25 Million USD | 1095.889% |
| Tilray Brands, Inc. | -174.74 Million USD | 129.943% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 68.661% |
| PetIQ, Inc. | 60.01 Million USD | 12.815% |
| Silver Spike Investment Corp. | 7.34 Million USD | -612.85% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 79.145% |
| Journey Medical Corporation | -2.07 Million USD | 2624.071% |
| Alimera Sciences, Inc. | -1.47 Million USD | 3657.036% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 484.245% |
| Assertio Holdings, Inc. | -243.53 Million USD | 121.485% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | 987.994% |
| Embecta Corp. | 221.5 Million USD | 76.377% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 360.967% |
| Procaps Group, S.A. | 38.97 Million USD | -34.257% |
| PainReform Ltd. | -9.58 Million USD | 645.952% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 137.957% |
| Hempacco Co., Inc. | -8.81 Million USD | 693.762% |
| Talphera, Inc. | -16.88 Million USD | 409.811% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 40.321% |
| Alvotech | -354.86 Million USD | 114.745% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 85.651% |
| Kamada Ltd. | 10.06 Million USD | -419.913% |
| Indivior PLC | -4 Million USD | 1408.1% |
| Currenc Group, Inc. | -6.64 Million USD | 887.326% |
| Evoke Pharma, Inc. | -7.43 Million USD | 804.142% |
| Flora Growth Corp. | -50.35 Million USD | 203.912% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 360.967% |
| Evolus, Inc. | -49.23 Million USD | 206.278% |
| HUTCHMED (China) Limited | 18.37 Million USD | -184.756% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 73.438% |
| Akanda Corp. | -10.05 Million USD | 620.566% |